Literature DB >> 28185869

Disease and economic burdens of dengue.

Marcia C Castro1, Mary E Wilson2, David E Bloom3.   

Abstract

The burden of dengue is large and growing. More than half of the global population lives in areas with risk of dengue transmission. Uncertainty in burden estimates, however, challenges policy makers' ability to set priorities, allocate resources, and plan for interventions. In this report, the first in a Series on dengue, we explore the estimations of disease and economic burdens of dengue, and the major estimation challenges, limitations, and sources of uncertainty. We also reflect on opportunities to remedy these deficiencies. Point estimates of apparent dengue infections vary widely, although the confidence intervals of these estimates overlap. Cost estimates include different items, are mostly based on a single year of data, use different monetary references, are calculated from different perspectives, and are difficult to compare. Comprehensive estimates that decompose the cost by different stakeholders (as proposed in our framework), that consider the cost of epidemic years, and that account for productivity and tourism losses, are scarce. On the basis of these estimates, we propose the most comprehensive framework for estimating the economic burden of dengue in any region, differentiated by four very different domains of cost items and by three potential stakeholders who bear the costs. This framework can inform future estimations of the economic burden of dengue and generate demand for additional routine administrative data collection, or for systematic incorporation of additional questions in nationally representative surveys in dengue-endemic countries. Furthermore, scholars could use the framework to guide scenario simulations that consider ranges of possible values for cost items for which data are not yet available. Results would be valuable to policy makers and would also raise awareness among communities, potentially improving dengue control efforts.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28185869     DOI: 10.1016/S1473-3099(16)30545-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  42 in total

Review 1.  Purinergic receptors and neglected tropical diseases: why ignore purinergic signaling in the search for new molecular targets?

Authors:  P A F Pacheco; L P Dantas; L G B Ferreira; Robson Xavier Faria
Journal:  J Bioenerg Biomembr       Date:  2018-06-07       Impact factor: 2.945

2.  Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells.

Authors:  Jenn-Haung Lai; Mei-Yi Wang; Chuan-Yueh Huang; Chien-Hsiang Wu; Li-Feng Hung; Chia-Ying Yang; Po-Yuan Ke; Shue-Fen Luo; Shih-Jen Liu; Ling-Jun Ho
Journal:  EMBO Rep       Date:  2018-06-07       Impact factor: 8.807

3.  Micronutrients, Immunological Parameters, and Dengue Virus Infection in Coastal Ecuador: A Nested Case-Control Study in an Infectious Disease Surveillance Program.

Authors:  Julia L Finkelstein; Susannah Colt; Alexander J Layden; Jesse T Krisher; Anna M Stewart-Ibarra; Mark Polhemus; Efraín Beltrán-Ayala; Julia M Tedesco; Washington B Cárdenas; Timothy Endy; Saurabh Mehta
Journal:  J Infect Dis       Date:  2020-01-01       Impact factor: 5.226

4.  Development and Performance of Dengue Diagnostic Clinical Algorithms in Colombia.

Authors:  Diana María Caicedo-Borrero; José Rafael Tovar; Andrés Méndez; Beatriz Parra; Anilza Bonelo; Jairo Celis; Liliana Villegas; Constanza Collazos; Lyda Osorio
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

5.  [Evidence synthesis: guidelines for diagnosis and treatment of dengue, chikungunya, and zika in the Region of the AmericasSíntese de evidências: diretrizes para o diagnóstico e o tratamento da dengue, chikungunya e zika na Região das Américas].

Authors: 
Journal:  Rev Panam Salud Publica       Date:  2022-07-20

Review 6.  Innate Immune Response to Dengue Virus: Toll-like Receptors and Antiviral Response.

Authors:  Caroline Fernandes-Santos; Elzinandes Leal de Azeredo
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

7.  Economic burden of dengue fever in China: A retrospective research study.

Authors:  Meng Xu; Nan Chang; Taotian Tu; Jimin Sun; Jinyong Jiang; Yu Xia; Wenge Tang; Hengqing Ji; Xiaotao Zhao; Jin Zhu; Li Qi; Xiaobo Liu; Qiyong Liu
Journal:  PLoS Negl Trop Dis       Date:  2022-05-20

8.  Lineage Replacement Associated with Fitness Gain in Mammalian Cells and Aedes aegypti: A Catalyst for Dengue Virus Type 2 Transmission.

Authors:  Cheong Huat Tan; Hapuarachchige Chanditha Hapuarachchi; Li Kiang Tan; Pei Sze Jeslyn Wong; Mei Zhi Irene Li; Wing Yan Wong; Lee Ching Ng
Journal:  Microorganisms       Date:  2022-05-26

9.  Physiologically Based Pharmacokinetic/Pharmacodynamic Model for the Treatment of Dengue Infections Applied to the Broad Spectrum Antiviral Soraphen A.

Authors:  Katharina Rox; Maxi Heyner; Jana Krull; Kirsten Harmrolfs; Valtteri Rinne; Juho Hokkanen; Gemma Perez Vilaro; Juana Díez; Rolf Müller; Andrea Kröger; Yuichi Sugiyama; Mark Brönstrup
Journal:  ACS Pharmacol Transl Sci       Date:  2021-08-30

10.  Temperature Increase Enhances Aedes albopictus Competence to Transmit Dengue Virus.

Authors:  Zhuanzhuan Liu; Zhenhong Zhang; Zetian Lai; Tengfei Zhou; Zhirong Jia; Jinbao Gu; Kun Wu; Xiao-Guang Chen
Journal:  Front Microbiol       Date:  2017-12-01       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.